Metraipolis › archive › dc_248fcd8fefe2

Canakinumab treatment in patients with colchicine-resistant familial mediterranean fever: a multicenter observational study — Europe PMC PMID:41816744

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41816744
DOI: 10.55730/1300-0144.6133
License (as archived): solo-consultazione
Archived: 2026-11-09T16:57:39.659Z
SHA-256 of the archived text: 637bbc5900e09a58e49aa533cfd53836f469c6d3db5dcb0f90944fcb7a2b9a72
Stable URL of this page: https://metraipolis.com/documento/dc_248fcd8fefe2

How to cite

Canakinumab treatment in patients with colchicine-resistant familial mediterranean fever: a multicenter observational study — Europe PMC PMID:41816744 — Europe PMC (en), https://europepmc.org/article/MED/41816744 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_248fcd8fefe2 (Metraipolis archive dc_248fcd8fefe2, sha256 637bbc5900e09a58e49aa533cfd53836f469c6d3db5dcb0f90944fcb7a2b9a72)

BibTeX

@misc{dc248fcd8fefe2,
  title = {Canakinumab treatment in patients with colchicine-resistant familial mediterranean fever: a multicenter observational study — Europe PMC PMID:41816744},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41816744},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_248fcd8fefe2; sha256 637bbc5900e09a58e49aa533cfd53836f469c6d3db5dcb0f90944fcb7a2b9a72},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41816744. Agents can read the archived copy with the MCP tool read_document.